Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
The CPT® Code 90665 refers to the Lyme disease vaccine specifically formulated for adult dosage and intended for intramuscular administration. Vaccines, unlike immune globulins, are designed to provide active, long-term immunity. This is achieved by introducing altered versions of specific pathogens, such as viruses or bacteria, into the body. The immune system responds by producing its own antibodies, which are crucial for defending against future infections by the same pathogen. In the case of Lyme disease, the causative agent is the bacterium Borrelia burgdorferi, which is primarily transmitted through the bite of infected ticks. Lyme disease can lead to serious complications if left untreated, potentially affecting the heart, joints, and nervous system. The use of this vaccine is essential in preventing the onset of Lyme disease by equipping the immune system to recognize and combat the bacterium effectively. It is important to note that this code specifically reports the vaccine product used, rather than the administration or any associated services.
© Copyright 2026 Coding Ahead. All rights reserved.
The Lyme disease vaccine is indicated for adults to prevent Lyme disease, which is caused by the bacterium Borrelia burgdorferi. The vaccine is particularly recommended for individuals who are at higher risk of exposure to infected ticks, such as those living in or traveling to endemic areas where Lyme disease is prevalent.
The administration of the Lyme disease vaccine involves several key procedural steps to ensure proper delivery and effectiveness of the vaccine.
Following the administration of the Lyme disease vaccine, patients may experience mild side effects, such as soreness at the injection site, low-grade fever, or fatigue. These symptoms are generally temporary and resolve on their own. Patients are advised to rest and stay hydrated. It is important for individuals to be informed about the potential side effects and to report any unusual or severe reactions to their healthcare provider. Additionally, patients should be educated on the importance of completing the full vaccination series, if applicable, to ensure optimal protection against Lyme disease.
| Short Descr | LYME DISEASE VACCINE IM | Medium Descr | LYME DISEASE VACCINE ADULT IM | Long Descr | Lyme disease vaccine, adult dosage, for intramuscular use | Status Code | Excluded from Physician Fee Schedule by Regulation | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Discontinued Code | Type of Service (TOS) | 1 - Medical Care | Berenson-Eggers TOS (BETOS) | O1G - Immunizations/Vaccinations | MUE | Not applicable/unspecified. | CCS Clinical Classification | 228 - Prophylactic vaccinations and inoculations |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2013-01-01 | Deleted | Code deleted |
| 2011-01-01 | Changed | Medium description changed. Short description changed. |
| 1999-01-01 | Added | Code added. |
Get instant expert-level medical coding assistance.